Stocks Overview

LAST PRICE
37.3100
TODAY'S CHANGE (%)
Trending Down-0.3100 (-0.8240%)

Bid / Lots
36.5100/ 10
Ask / Lots
41.0000/ 6
Open / Previous Close
37.5500 / 37.6200
Day Range
Low 36.5599
High 37.6550
52 Week Range
Low 35.4401
High 54.4446
Volume
1,363,052
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 37.62
Time	Volume	IONS
09:32 ET	8979	37.555
09:34 ET	533	37.525
09:36 ET	940	37.61
09:38 ET	900	37.32
09:39 ET	778	37.3
09:41 ET	700	37.235
09:43 ET	1801	37.26
09:45 ET	3385	37.465
09:48 ET	16945	37.52
09:50 ET	4709	37.295
09:52 ET	1886	37.4
09:54 ET	1473	37.34
09:56 ET	1317	37.2411
09:57 ET	1761	37.345
09:59 ET	4347	37.325
10:01 ET	33584	37.3
10:03 ET	3400	37.19
10:06 ET	1570	37.22
10:08 ET	2200	37.16
10:10 ET	1326	37.17
10:12 ET	3111	37.05
10:14 ET	2524	37.1
10:15 ET	1000	37.055
10:17 ET	18803	36.71
10:19 ET	10836	36.785
10:21 ET	14695	36.84
10:24 ET	8502	36.905
10:26 ET	2561	36.9175
10:28 ET	6570	36.94
10:30 ET	3183	36.97
10:32 ET	5256	36.98
10:33 ET	14197	36.88
10:35 ET	9016	36.86
10:37 ET	3800	36.82
10:39 ET	800	36.8
10:42 ET	3300	36.86
10:44 ET	907	36.81
10:46 ET	2185	36.8
10:48 ET	5132	36.855
10:50 ET	100	36.855
10:51 ET	800	36.845
10:53 ET	3459	36.977
10:55 ET	3234	37.02
10:57 ET	4606	36.915
11:00 ET	4486	36.94
11:02 ET	4923	36.98
11:04 ET	899	36.97
11:06 ET	688	36.96
11:08 ET	22426	36.86
11:09 ET	3465	36.85
11:11 ET	4450	36.845
11:13 ET	14099	36.8
11:15 ET	1308	36.835
11:18 ET	3412	36.86
11:20 ET	559	36.85
11:22 ET	2535	36.8
11:24 ET	1790	36.815
11:26 ET	956	36.77
11:27 ET	574	36.8
11:29 ET	500	36.79
11:31 ET	2957	36.81
11:33 ET	345	36.81
11:36 ET	1765	36.82
11:38 ET	1203	36.84
11:40 ET	2579	36.86
11:42 ET	4193	36.85
11:44 ET	1779	36.78
11:45 ET	9242	36.66
11:47 ET	1100	36.65
11:49 ET	6196	36.71
11:51 ET	2932	36.72
11:54 ET	4724	36.735
11:56 ET	1328	36.73
11:58 ET	4610	36.71
12:00 ET	1657	36.705
12:02 ET	1431	36.76
12:03 ET	3067	36.735
12:05 ET	500	36.72
12:07 ET	1200	36.727
12:09 ET	1219	36.69
12:12 ET	755	36.72
12:14 ET	1168	36.715
12:16 ET	440	36.725
12:18 ET	600	36.715
12:20 ET	2345	36.7442
12:21 ET	400	36.735
12:23 ET	1119	36.67
12:25 ET	4949	36.67
12:27 ET	100	36.66
12:30 ET	1100	36.62
12:32 ET	200	36.61
12:34 ET	729	36.635
12:36 ET	2935	36.665
12:38 ET	130	36.6501
12:39 ET	702	36.68
12:41 ET	800	36.675
12:43 ET	4173	36.645
12:45 ET	858	36.62
12:48 ET	100	36.62
12:50 ET	700	36.63
12:52 ET	2959	36.64
12:54 ET	1100	36.66
12:56 ET	100	36.67
12:57 ET	1600	36.635
12:59 ET	700	36.63
01:01 ET	1532	36.625
01:03 ET	1489	36.625
01:06 ET	1995	36.625
01:08 ET	2306	36.64
01:10 ET	2982	36.66
01:12 ET	1500	36.64
01:14 ET	11143	36.71
01:15 ET	3289	36.77
01:17 ET	1869	36.77
01:19 ET	1200	36.79
01:21 ET	2948	36.76
01:24 ET	3376	36.79
01:26 ET	1100	36.805
01:28 ET	400	36.8
01:30 ET	200	36.81
01:32 ET	600	36.78
01:33 ET	906	36.75
01:35 ET	500	36.72
01:37 ET	1423	36.71
01:39 ET	2234	36.67
01:42 ET	1826	36.655
01:44 ET	4564	36.64
01:46 ET	2425	36.66
01:48 ET	700	36.6478
01:50 ET	200	36.645
01:51 ET	2443	36.66
01:53 ET	1300	36.635
01:55 ET	7066	36.63
01:57 ET	505	36.63
02:00 ET	802	36.64
02:02 ET	1861	36.619
02:04 ET	2140	36.59
02:06 ET	1463	36.61
02:08 ET	8073	36.7
02:09 ET	2100	36.735
02:11 ET	2354	36.675
02:13 ET	1127	36.63
02:15 ET	1800	36.615
02:18 ET	2524	36.64
02:20 ET	1850	36.595
02:22 ET	4009	36.57
02:24 ET	2936	36.565
02:26 ET	2932	36.62
02:27 ET	2045	36.605
02:29 ET	708	36.64
02:31 ET	1317	36.62
02:33 ET	2918	36.61
02:36 ET	704	36.6
02:38 ET	500	36.61
02:40 ET	1083	36.6
02:42 ET	2800	36.615
02:44 ET	1095	36.625
02:45 ET	3067	36.665
02:47 ET	6097	36.66
02:49 ET	3624	36.64
02:51 ET	600	36.64
02:54 ET	600	36.64
02:56 ET	4293	36.65
02:58 ET	1931	36.63
03:00 ET	1204	36.65
03:02 ET	6703	36.65
03:03 ET	200	36.655
03:05 ET	618	36.655
03:07 ET	1367	36.67
03:09 ET	5489	36.71
03:12 ET	617	36.72
03:14 ET	2151	36.75
03:16 ET	300	36.745
03:18 ET	985	36.745
03:20 ET	3723	36.78
03:21 ET	11852	36.865
03:23 ET	5446	36.845
03:25 ET	1834	36.91
03:27 ET	2113	37.02
03:30 ET	4679	36.93
03:32 ET	8604	36.872
03:34 ET	3777	36.85
03:36 ET	1645	36.825
03:38 ET	1440	36.82
03:39 ET	2990	36.85
03:41 ET	3362	36.86
03:43 ET	3437	36.84
03:45 ET	2804	36.845
03:48 ET	4091	36.94
03:50 ET	9161	37.001
03:52 ET	10446	37.115
03:54 ET	12129	37.13
03:56 ET	17747	37.225
03:57 ET	22527	37.23
03:59 ET	47909	37.31

Data delayed at least 15 minutes.

May 16, 2024
- DJ Ionis to Fly Solo on Angelman Syndrome Drug -- Market Talk, from 11:52AM ET on Thursday May 16, 2024 by Dow Jones
  11:52AM ET on Thursday May 16, 2024 by Dow Jones
- DJ Biogen, Ionis Terminate Development of BIIB105 for Amyotrophic Lateral Sclerosis, from 8:05AM ET on Thursday May 16, 2024 by Dow Jones
  8:05AM ET on Thursday May 16, 2024 by Dow Jones
- Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis, from 7:30AM ET on Thursday May 16, 2024 by Dow Jones
  7:30AM ET on Thursday May 16, 2024 by Dow Jones
- Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis, from 7:30AM ET on Thursday May 16, 2024 by Dow Jones
  7:30AM ET on Thursday May 16, 2024 by Dow Jones
- Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome, from 7:00AM ET on Thursday May 16, 2024 by Dow Jones
  7:00AM ET on Thursday May 16, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesIONS Ionis Pharmaceuticals Inc	5.4B	-14.0x	---
United StatesHALO Halozyme Therapeutics Inc	5.7B	18.5x	---
United StatesAPLS Apellis Pharmaceuticals Inc	5.0B	-11.9x	---
United StatesCRSP CRISPR Therapeutics AG	4.8B	-20.8x	---
United StatesACAD ACADIA Pharmaceuticals Inc	2.4B	-1,149.2x	---
United StatesITCI Intra-Cellular Therapies Inc	6.9B	-56.4x	---
As of 2024-05-18

Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).

Contact Information

Headquarters: 2855 Gazelle CourtCARLSBAD, CA, United States 92010
Phone: 760-931-9200
Fax: 302-655-5049

Executives

Independent Chairman of the Board: Joseph Loscalzo
Chief Executive Officer, Director: Brett Monia
Chief Financial Officer, Executive Vice President - Finance: Elizabeth Hougen
Executive Vice President, Chief Scientific Officer: C. Frank Bennett
Executive Vice President, Chief Business Officer: Joseph Baroldi

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$5.4B
Revenue (TTM)	$776.6M
Shares Outstanding	146.0M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.34
EPS	$-2.67
Book Value	$2.68
P/E Ratio	-14.0x
Price/Sales (TTM)	7.0
Price/Cash Flow (TTM)	---
Operating Margin	-45.47%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Ionis Pharmaceuticals Inc
NASDAQ:IONSUnited States

Search Criteria

Charts

Recent News

May 16, 2024

DJ Ionis to Fly Solo on Angelman Syndrome Drug -- Market Talk, from 11:52AM ET on Thursday May 16, 2024 by Dow Jones

DJ Biogen, Ionis Terminate Development of BIIB105 for Amyotrophic Lateral Sclerosis, from 8:05AM ET on Thursday May 16, 2024 by Dow Jones

Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis, from 7:30AM ET on Thursday May 16, 2024 by Dow Jones

Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis, from 7:30AM ET on Thursday May 16, 2024 by Dow Jones

Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome, from 7:00AM ET on Thursday May 16, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar